Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M30.3Revenue (TTM) $M12.9Net Margin (%)-292.4Altman Z-Score-4.9
Enterprise Value $M24.6EPS (TTM) $-9.1Operating Margin %-69.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.5Pre-tax Margin (%)-292.4Higher ROA y-yN
Price/Book0.810-y EBITDA Growth Rate %-8.8Quick Ratio2.2Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %14.1Current Ratio3.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-111.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M9.8ROIC % (ttm)-30.7Gross Margin Increase y-yY

Gurus Latest Trades with KOOL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KOOLKen Fisher 2011-09-30 Sold Out -0.0001%$24 - $42.6
($34.42)
$ 3.19-91%Sold Out0
KOOLKen Fisher 2011-06-30 Buy $38.2 - $49.4
($43.87)
$ 3.19-93%New holding1,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KOOL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


KOOL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Harris KennethFormer Director/Officer 2015-11-10Sell4,043$12-73.42view
Harris KennethFormer Director/Officer 2015-11-03Sell526$12-73.42view
Harris KennethFormer Director/Officer 2015-10-29Sell432$12-73.42view
Plavan Matthew TFormer CEO 2015-09-02Sell864$13.6-76.54view
Rhein Denis MichaelDirector 2014-12-01Sell0$0-76.54view
ENGLE J MELVILLEChairman & CEO 2011-03-10Buy1,125$46-93.07view
ARTILES JORGEVP, Quality/Regulatory Affairs 2010-01-13Buy5$48.8-93.46view
ENGLE J MELVILLECEO 2009-09-25Buy1,250$45.6-93view
MCENANY PATRICK JDirector 2009-05-19Buy313$46.4-93.13view
ENGLE J MELVILLECEO 2009-05-12Buy1,250$44-92.75view

Quarterly/Annual Reports about KOOL:

News about KOOL:

Articles On GuruFocus.com
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 11 2011 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 04 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 04 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 09 2009 
THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares Sep 28 2009 
THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares May 12 2009 
THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2009 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 05 2009 

More From Other Websites
6:01 am Cesca Therapeutics submits an Investigational Device Exemption Supplement to the FDA for its... Dec 05 2016
Cesca Submits IDE Supplement for CLI Pivotal Trial Dec 05 2016
Cesca Therapeutics to Present at the 9th Annual LD Micro Main Event Dec 02 2016
CESCA THERAPEUTICS INC. Financials Nov 24 2016
Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q1, 2017 By the Numbers : November 23, 2016 Nov 23 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Financial Statements and Exhibits Nov 22 2016
Cesca Therapeutics Reports First Quarter Fiscal 2017 Results and Provides Business Update Nov 17 2016
Q1 2017 Cesca Therapeutics Inc Earnings Release - After Market Close Nov 17 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K/A, Triggering Events That Accelerate or Increase a Direct... Nov 17 2016
Cesca Therapeutics to Announce First Quarter Fiscal 2017 Results on November 17, 2016 Nov 16 2016
Arcadia Biosciences Announces Third-Quarter 2016 Financial Results and Business Highlights Nov 10 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers Nov 09 2016
Boyalife Announces Recent Changes to Management and the Board of Directors of Cesca Therapeutics by... Nov 04 2016
Why Are Traders Piling Into These Five Stocks? Oct 24 2016
CESCA THERAPEUTICS GRANTED THIRD U.S. PATENT RELATING TO ITS PROPRIETARY SURGWERKSTM PLATFORM Oct 18 2016
Cesca Therapeutics Granted Third U.S. Patent Relating to Its Proprietary SurgWerks™ Platform Oct 18 2016
Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: 2016 By the Numbers : September 28, 2016 Sep 28 2016
Cesca Therapeutics to Present & Exhibit at the ISCT North America 2016 Regional Meeting Sep 27 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Financial Statements and Exhibits Sep 26 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Sep 21 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)